Crossmark

Effect of combining targeted therapies or chemotherapy with stereotactic radiosurgery (SRS) on the prognosis of patients with brain metastases from non-small cell lung cancer (NSCLC)

Crossref DOI link: https://doi.org/10.1007/s11060-025-05346-w

Published Online: 2025-12-23

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ron, Guy N.

Ron, Ilan G.

Kantor, Halit

Fening, Eyal

Yust-Katz, Shlomit

Amiel, Alexandra

Laviv, Yosef

Corn, Benjamin W.

Kanner, Andrew A.
License Information

Text and Data Mining valid from 2025-12-23

Version of Record valid from 2025-12-23
More Information

Article History

Received: 24 October 2025

Accepted: 19 November 2025

First Online: 23 December 2025

Change Date: 27 December 2025

Change Type: Update

Change Details: The original version of this article has been revised: The last author's first affiliation has been corrected.

Declarations

:

: This study was approved by the local institutional review board (ethics approval number 0624-19-RMC). Due to the retrospective nature of the study, written informed consent was waived.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below